首页 / 资源中心 / 客户发表文献

Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression

发表时间:2024-09-13 访问次数:4
文章推荐